Abstracts

P4-1

Deoxybouvardin-glucoside inhibits the growth of non-small cell lung cancer cells by inducing apoptosis via the suppression of EGFR/MET/AKT signaling

Na Yeong Lee, Jung-Hyun Shim^*
P4-2

Deoxybouvardin suppresses non-small cell lung cancer cell growth by inhibiting EGFR, MET, and AKT

A-Young Nam, Jung-Hyun Shim^*
P4-4

Cyclic RGD Pentapeptide Cilengitide Enhances Efficacy of Gefitinib on TGF-β1-Induced Epithelial-to-Mesenchymal Transition and Invasion in Human Non-Small Cell Lung Cancer Cells

Yeon soo Kim, Jay Seo, Hye Eun Kang, Jiyeon Kim^*

TODAY 2025. 03. 14

2025 Spring Convention

D-38

Conference infomation

Conference Schedule

Apr. 21(Mon) ~ 22(Tue), 2025

Conference Venue

Daegu Exhibition & Convention Center (EXCO) 10 Exco-ro, Buk-gu, Daegu, Republic of Korea

Location

Early Registration Period

Feb. 24(Mon) ~ Mar. 21(Fri), 2025

Go to submit

Abstract Submission Period

Feb. 24(Mon) ~ Mar. 21(Fri), 2025

Go to submit

Certificate of Attendance

Go to issue

2025 Spring International Convention of
The Pharmaceutical Society of Korea

06708) 194, Hyoryeong-ro, Seocho-gu, Seoul, Republic of Korea / Tel : 02-584-3257 / Fax : 02-521-1781 Business Registration Number : 214-82-00319 / President : Hyung Sik Kim / E-mail : psk1946@psk.or.kr

2025 Spring International Convention of
The Pharmaceutical Society of Korea

2025 Spring
International Convention of PSK

Abstracts

P4. Biochemistry / Molecular Biology

Conference infomation

2025 Spring International Convention of
The Pharmaceutical Society of Korea

2025 Spring International Convention of The Pharmaceutical Society of Korea

2025 Spring International Convention of PSK

Abstracts

P4. Biochemistry / Molecular Biology

Conference infomation

2025 Spring International Convention of The Pharmaceutical Society of Korea

2025 Spring International Convention of
The Pharmaceutical Society of Korea

2025 Spring
International Convention of PSK

2025 Spring International Convention of
The Pharmaceutical Society of Korea